about
Independent data validation of an in vitro method for the prediction of the relative bioavailability of arsenic in contaminated soils.Comparison of indigenous and exogenous microbial populations during slurry phase biodegradation of long-term hydrocarbon-contaminated soil.A polyphasic approach for assessing the suitability of bioremediation for the treatment of hydrocarbon-impacted soil.Potential impact of soil microbial heterogeneity on the persistence of hydrocarbons in contaminated subsurface soils.Arsenic Relative Bioavailability in Rice Using a Mouse Arsenic Urinary Excretion Bioassay and Its Application to Assess Human Health Risk.Assessing the bioavailability and bioaccessibility of metals and metalloids.Applying Cadmium Relative Bioavailability to Assess Dietary Intake from Rice to Predict Cadmium Urinary Excretion in Nonsmokers.Influence of sample matrix on the bioavailability of arsenic, cadmium and lead during co-contaminant exposure.Advances in in vitro methods to evaluate oral bioaccessibility of PAHs and PBDEs in environmental matrices.Lead relative bioavailability in soils based on different endpoints of a mouse model.Influence of co-contaminant exposure on the absorption of arsenic, cadmium and lead.Biochar increases arsenic release from an anaerobic paddy soil due to enhanced microbial reduction of iron and arsenic.A critical review of approaches and limitations of inhalation bioavailability and bioaccessibility of metal(loid)s from ambient particulate matter or dust.Oral relative bioavailability of Dichlorodiphenyltrichloroethane (DDT) in contaminated soil and its prediction using in vitro strategies for exposure refinement.Lead Relative Bioavailability in Lip Products and Their Potential Health Risk to Women.Using the SBRC Assay to Predict Lead Relative Bioavailability in Urban Soils: Contaminant Source and Correlation Model.Assessment of arsenic speciation and bioaccessibility in mine-impacted materials.Predicting the Relative Bioavailability of DDT and Its Metabolites in Historically Contaminated Soils Using a Tenax-Improved Physiologically Based Extraction Test (TI-PBET).Arsenic Relative Bioavailability in Contaminated Soils: Comparison of Animal Models, Dosing Schemes, and Biological End Points.Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assays.Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.Predicting oral relative bioavailability of arsenic in soil from in vitro bioaccessibility.Assessment of lead bioaccessibility in peri-urban contaminated soils.Impact of soil particle size and bioaccessibility on children and adult lead exposure in peri-urban contaminated soils.Predicting Arsenic Relative Bioavailability Using Multiple in Vitro Assays: Validation of in Vivo-in Vitro Correlations.Comparison of arsenic bioaccessibility in housedust and contaminated soils based on four in vitro assays.In vivo bioavailability and in vitro bioaccessibility of perfluorooctanoic acid (PFOA) in food matrices: correlation analysis and method development.Microbial degradation and detoxification of high molecular weight polycyclic aromatic hydrocarbons by Stenotrophomonas maltophilia strain VUN 10,003.Assessment of five bioaccessibility assays for predicting the efficacy of petroleum hydrocarbon biodegradation in aged contaminated soils.Determination of cadmium relative bioavailability in contaminated soils and its prediction using in vitro methodologies.Chemical bioavailability in the terrestrial environment - recent advances.Correlation of in vivo relative bioavailability to in vitro bioaccessibility for arsenic in household dust from China and its implication for human exposure assessment.Metabolite repression inhibits degradation of benzo[a]pyrene and dibenz[a,h]anthracene by Stenotrophomonas maltophilia VUN 10,003.Biosorption of organochlorine pesticides using fungal biomass.Influence of in vitro assay pH and extractant composition on As bioaccessibility in contaminated soils.Influence of saliva, gastric and intestinal phases on the prediction of As relative bioavailability using the Unified Bioaccessibility Research Group of Europe Method (UBM).Evaluation of SBRC-gastric and SBRC-intestinal methods for the prediction of in vivo relative lead bioavailability in contaminated soils.Assessment of in vitro lead bioaccessibility in house dust and its relationship to in vivo lead relative bioavailability.Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices.Microbial Degradation of Phenanthrene in Pristine and Contaminated Sandy Soils.
P50
Q30949933-AC7E9B60-E9BB-43FB-9AB6-73E1E419337DQ34298751-6D4EC5F4-FC12-40F6-BF71-FFDB57265171Q34605262-261E4D07-3684-419B-84C5-D9AA9B43DCE4Q35098343-52DADF7A-84FF-4982-85F5-C2D5E7676F09Q36310080-C684509F-84DE-489F-AF05-31BBF502B31BQ38114325-9FD5B427-D673-42D2-98FE-1F1ABA6E4CFBQ38685561-A5F0A9F3-9E40-4644-B19C-43A52D935B9EQ38730683-91E0D0E1-E318-4565-903C-E9D1DD5882E6Q38752651-45C6B125-EF90-4CC7-AA28-13D9A760E35AQ38780775-8C8F2805-B7F9-4892-B9E6-96F1D2E49F7DQ38796331-B88EDEBC-F4E5-4357-9AC9-105C90B3A523Q38813309-41FF1435-6F9C-4DD5-9A8E-01D3BD398550Q38817284-25EE12D5-B6FD-41C4-B222-0285E13F2577Q38841291-37367ED6-7205-4CD2-8A82-B7DB1C0A2F42Q38866285-14433E4C-A3E6-437F-886E-07DF2BA1BE77Q38879131-505471C2-EA45-4C7F-A41A-FC4D7956BF8EQ38883732-10A75BF4-451E-45F3-A606-732003278F07Q38926764-262F8A2A-E8A8-4AD0-959C-F69277C7074CQ38939927-34A3DB2B-B4AB-40F0-8779-4D98131351C6Q39461308-FDC0536F-8DAA-4979-BE76-3C3AD408A6E0Q39656263-4B3F23B8-1320-45B7-8875-06FB60761C81Q39876701-E0589D1F-12C2-4A89-92F0-37DE15107714Q39960633-D902B955-D884-4E8B-9F2D-977C16B955D7Q39967151-766E511C-EFA1-4135-91FB-9852D6C0B7A5Q40613455-6F23AE6A-7251-46B6-A7FF-5506E357BF7EQ40774716-7286B792-1264-4AEB-90D9-814E389D7E20Q41678656-318C9EED-2702-4600-B1B2-43F4895F24FDQ42487464-067EC0D4-F5AF-453E-B6F4-67B8D7AB7528Q42858815-F3B26C49-E8D4-469C-A76E-E330B8FF5BB3Q43043147-BF310735-7D6D-4DF7-B713-56B167B61CA0Q43785863-9E31F44F-1F89-48FF-8F3C-DCBD185B12E4Q43863251-869EB21A-EE4C-4364-9A84-ECDBF3EBE483Q44034581-9F4574DF-9E0B-4B33-BBF6-41D3325C53F5Q44159556-E33DF68B-4B6D-4F00-BD0F-7BAE372B8BA5Q45161890-116B1375-9F80-49AC-A5F8-0FA9AEBD5BA3Q45807426-2E989C1F-9B4B-46BE-B378-05D392DA9158Q45928841-1DDDAC9D-F91F-4874-AFA2-DBA157E3AB2AQ46110428-873DDF69-F665-41DA-A36C-E7EA1BDE6E59Q46125787-9E611DBD-C925-45E4-94EC-57B16C18F475Q46272849-35E51907-4194-4614-8508-AF40C9198A41
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Albert L Juhasz
@nl
Albert L Juhasz
@sl
Albert L. Juhasz
@en
Albert L. Juhasz
@es
type
label
Albert L Juhasz
@nl
Albert L Juhasz
@sl
Albert L. Juhasz
@en
Albert L. Juhasz
@es
altLabel
A.L. Juhasz
@en
Albert L. Juhasz
@en
prefLabel
Albert L Juhasz
@nl
Albert L Juhasz
@sl
Albert L. Juhasz
@en
Albert L. Juhasz
@es
P1053
F-6600-2011
P106
P1153
7101843609
P2038
Albert_Juhasz3
P21
P31
P3829
P496
0000-0002-1164-4085